Search

everythinglearnresearchcommunity

for

Search:↓

A defective protein in progeria causes cell death and atherosclerosis, but a treatment targeting cell stress may reduce these effects.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

More exercise might link to hair loss, but other factors also matter.

Oncoplastic breast surgery is more cost-effective than standard lumpectomy for large-breasted women despite being more expensive.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Helminth protein helps wounds heal better by reducing scarring and promoting tissue growth.

Lack of Cisd2 disrupts calcium balance in cells, leading to poorly functioning neutrophils.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Using old drugs for new uses can help treat rare immune deficiencies.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Stem cell-derived conditioned medium shows promise for treating various medical conditions but requires standardized production and further validation.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Targeted cancer therapies often cause serious skin problems that need careful management.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Alopecia areata treatment varies, with no optimal method established yet.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Some common medications can harm male fertility, but many effects can be reversed.